SkyView Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,456
Closed -$266K 630
2023
Q2
$266K Sell
3,456
-7,343
-68% -$568K 0.07% 333
2023
Q1
$811K Buy
10,799
+1,008
+10% +$75K 0.19% 141
2022
Q4
$771K Sell
9,791
-789
-7% -$59.2K 0.23% 139
2022
Q3
$743K Buy
10,580
+629
+6% +$49.3K 0.22% 157
2022
Q2
$798K Sell
9,951
-2,212
-18% -$173K 0.21% 157
2022
Q1
$927K Buy
12,163
+588
+5% +$46.6K 0.22% 147
2021
Q4
$996K Buy
11,575
+1,577
+16% +$123K 0.22% 120
2021
Q3
$756K Buy
9,998
+5,223
+109% +$415K 0.21% 131
2021
Q2
$377K Hold
4,775
0.18% 121
2021
Q1
$377K Buy
4,775
+344
+8% +$27K 0.17% 128
2020
Q4
$379K Buy
+4,431
New +$366K 0.18% 114

Other funds holding CL

SkyView Investment Advisors's CL Position: Q3 2023 in Review

SkyView Investment Advisors sold out of Colgate-Palmolive (CL) in Q3 2023, closing a stake of 3,456 shares — an estimated $266K sold.

SkyView Investment Advisors first reported a position in CL in Q4 2020 and held it in 11 quarters. The position peaked at $996K in Q4 2021. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • SkyView Investment Advisors reported no remaining Colgate-Palmolive position as of Q3 2023 after selling out during the quarter.
  • SkyView Investment Advisors sold 3,456 Colgate-Palmolive shares in Q3 2023, an estimated $266K.
  • SkyView Investment Advisors first reported a position in Colgate-Palmolive in Q4 2020 and held it in 11 quarters.
  • SkyView Investment Advisors's Colgate-Palmolive position peaked at $996K in Q4 2021.
  • 1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on SkyView Investment Advisors's 13F filing for Q3 2023, filed 17 Nov 2023.